Monitor the December 1 special meeting vote outcome. If the reverse split is approved, watch for the board's decision on the final ratio and effective date. If not approved, delisting proceedings could begin, making the stock highly illiquid.
Price Chart
Executive Summary
Accendra Health is holding a special shareholder meeting on December 1, 2026, to vote on a reverse stock split (1-for-20 to 1-for-30) and an adjournment proposal. The reverse split is needed to regain NYSE compliance after the company received a non-compliance notice on October 6, 2026, because its average closing price fell below $1.00 per share over 30 consecutive trading days. Failure to approve the split could lead to delisting, severely impacting liquidity and the company's ability to raise capital.
Key Facts
- NYSE notified Accendra on October 6, 2026 of non-compliance with the $1.00 minimum average closing price rule over 30 consecutive trading days.
- The company has a six-month cure period and is seeking shareholder approval for a reverse stock split at a ratio between 1-for-20 and 1-for-30.
- As of the record date (October 27, 2026), there were 76,965,322 shares outstanding; the company's market cap is $16M.
- If the reverse split is not approved, the NYSE will commence delisting proceedings, which could impair liquidity and capital access.
- The board reserves the right to abandon the reverse split even if approved.
- Top shareholders: Coliseum Capital Management (17.02%), Bank of America (10.75%), BlackRock (7.09%), Kevin M. Webb (5.57%).
- No executive compensation, say-on-pay, director elections, shareholder proposals, or related party transactions are addressed in this special meeting proxy.
- The company has retained Georgeson, LLC for proxy solicitation at approximately $20,000 plus expenses.
Financial Impact
No financial data provided; the reverse split does not change market capitalization (except for fractional share cash-outs). Delisting risk is material given the $16M market cap.
Risk Factors
- Reverse split may not raise the stock price sufficiently to regain NYSE compliance.
- If delisted, trading would move to OTC markets with significantly reduced liquidity.
- NYSE rules restrict another reverse split within 12 months if compliance is lost again.
- Short squeeze risk post-split could cause extreme price volatility.
- Odd-lot holders may face higher transaction costs.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEF 14A Filing (Primary) | 0001104659-26-120208 |
| Document: 0001104659-26-120208-index-headers.html | 0001104659-26-120208 |
| Document: 0001104659-26-120208-index.html | 0001104659-26-120208 |
| Document: 0001104659-26-120208.txt | 0001104659-26-120208 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 30, 2026 2d ago | 8-K | $0.2500 | awaiting T+5 | awaiting T+5 | $0.2500 (0.00%) |
Oct 29, 2026 3d ago | DEF 14A | $0.2300 | awaiting T+5 | awaiting T+5 | $0.2500 (−8.70%) |
Oct 9, 2026 23d ago | 8-K | $0.3905 $0.2202 | ▲ +43.61% | ▲ +42.12% | $0.2500 (+35.98%) |
Oct 7, 2026 25d ago | SC 13G | $0.4729 $0.3128 | ▼ −33.85% | ▼ −32.87% | $0.2500 (−47.13%) |
Sep 17, 2026 6w ago | 8-K | $1.03 $0.7332 | ▼ −28.82% | ▼ −29.42% | $0.2500 (−75.73%) |
Aug 17, 2026 10w ago | 8-K | $1.07 $1.16 | ▲ +8.41% | ▲ +9.60% | $0.2500 (−76.64%) |
Aug 16, 2026 10w ago | Institutional Cluster | $1.07 $1.16 | ▲ +8.41% | ▲ +9.60% | $0.2500 (−76.64%) |
Aug 10, 2026 11w ago | 8-K | $1.26 $1.13 | ▼ −10.32% | ▼ −9.91% | $0.2500 (−80.16%) |
Aug 10, 2026 11w ago | 8-K | $1.40 $1.07 | ▲ +23.57% | ▲ +23.52% | $0.2500 (+82.14%) |
Aug 10, 2026 11w ago | 8-K | $1.40 $1.07 | ▼ −23.57% | ▼ −23.52% | $0.2500 (−82.14%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers